{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:29:55Z","timestamp":1754159395181,"version":"3.41.2"},"reference-count":19,"publisher":"Vilnius University Press","issue":"2","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AML"],"abstract":"<jats:p>Introduction:\u00a0Immunoglobulin A vasculitis (IgAV) is the most common vasculitis in children. Although typically self-limiting, IgAV may result in serious complications. Our objective was to evaluate the incidence, clinical features, laboratory predictors and outcomes of IgA vasculitis with gastrointestinal (GI) and kidney involvement.Methods:\u00a0Medical records of patients &lt;18 years of age with newly diagnosed IgAV between 2013 and 2021 in a single center were analyzed. Demographic, clinical, laboratory data, and incidence of GI and kidney involvement data were analyzed. As laboratory predictors, neutrophil, lymphocyte, platelets count, mean platelet volume (MPV) and neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) were calculated.Results:\u00a0240 patients with IgAV were included. GI involvement was in 104 patients (43.3%), whereas kidney involvment in 21 patients (8.8%).\u00a0 Age was the only variable associated with increased odds of kidney involvement (OR 3.5, 95% confidence interval 1.39\u20138.56, p=0.009). None of the laboratory predictors or other tested variables was associated with kidney involvement in univariable logistic regression. The neutrophil and lymphocyte count, NLR and PLR levels were found to be significantly higher in children with GI involvement. There were no bad outcomes: lethal outcome or chronic kidney disease for the patients with GI and kidney involvement in recent study. During two years of surveillance after IgAV diagnosis, 11 cases (4.6%) had indications for kidney biopsy and were diagnosed with IgAV nephritis.Conclusions:\u00a0\u00a0Older children were more likely to have kidney disease. Easy obtained laboratory parameters such as NLP, PLR could help to predict GI involvement in early disease stage, but had no value for predicting kidney involvement.<\/jats:p>","DOI":"10.15388\/amed.2024.31.2.4","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T01:27:02Z","timestamp":1738718822000},"page":"254-263","source":"Crossref","is-referenced-by-count":0,"title":["Possible Threats of IgA Vasculitis in Children: One Center Experience"],"prefix":"10.15388","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9041-0697","authenticated-orcid":false,"given":"Egl\u0117","family":"Lanzbergait\u0117-Manuilova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-1045","authenticated-orcid":false,"given":"Skirmant\u0117","family":"Rusonien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7767-2102","authenticated-orcid":false,"given":"Augustina","family":"Jankauskien\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6097","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Kim WK, Kim CJ, Yang EM. Risk factors for renal involvement in Henoch-Sch\u00f6nlein purpura. J Pediatr (Rio J). 2021;97(6):646-650. doi:10.1016\/j.jped.2021.01.008","DOI":"10.1016\/j.jped.2021.01.008"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Yuan Y, Liu J, Zhou Y, et al. The relationship between monocyte-to-lymphocyte ratio and the risk of gastrointestinal system involvement in children with IgA vasculitis: A preliminary report. Adv Clin Exp Med. 2021;30(10):999-1005. doi:10.17219\/acem\/138906","DOI":"10.17219\/acem\/138906"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Oni L, Sampath S. Childhood IgA Vasculitis (Henoch Schonlein Purpura)-Advances and Knowledge Gaps. Front Pediatr. 2019;7:257. doi:10.3389\/fped.2019.00257","DOI":"10.3389\/fped.2019.00257"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Zhao Y, Kumar Yadav P, Pan Y, Niu S, Zhang S, Wang H, Wang Z. Analysis of 135 Cases of Pediatric Henoch-Sch\u00f6nlein Purpura in Gansu, Northwestern China. Iran J Pediatr. 2019;29(6):e90663. doi:10.5812\/ijp.90663","DOI":"10.5812\/ijp.90663"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Li B, Ren Q, Ling J, Tao Z, Yang X, Li Y. Clinical relevance of neutrophil-to-lymphocyte ratio and mean platelet volume in pediatric Henoch-Schonlein Purpura: a meta-analysis. Bioengineered. 2021;12(1):286-295. doi:10.1080\/21655979.2020.1865607","DOI":"10.1080\/21655979.2020.1865607"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Lei W, Yun-Yun S, Ai-E X. Neutrophil-to-lymphocyte ratio: A biomarker for predicting systemic involvement in Henoch-Schonlein purpura. Indian J Dermatol Venereol Leprol. 2022;88(1):132. doi:10.25259\/IJDVL_760_19","DOI":"10.25259\/IJDVL_760_19"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Coppo R. Pediatric IgA Nephropathy in Europe. Kidney Dis (Basel). 2019;5(3):182-188. doi:10.1159\/000495751","DOI":"10.1159\/000495751"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Yoshikawa N, Tanaka R, Iijima K. Pathophysiology and treatment of IgA nephropathy in children. Pediatr Nephrol. 2001;16(5):446-457. doi:10.1007\/s004670100582","DOI":"10.1007\/s004670100582"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Wu H, Fang X, Xia Z, et al. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience. J Nephrol. 2020;33(6):1263-1273. doi:10.1007\/s40620-020-00767-4","DOI":"10.1007\/s40620-020-00767-4"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Ozen S, Pistorio A, Iusan SM, et al. EULAR\/PRINTO\/PRES criteria for Henoch-Sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010;69(5):798-806. doi:10.1136\/ard.2009.116657","DOI":"10.1136\/ard.2009.116657"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Song Y, Huang X, Yu G, et al. Pathogenesis of IgA Vasculitis: An Up-To-Date Review. Front Immunol. 2021;12:771619. doi:10.3389\/fimmu.2021.771619","DOI":"10.3389\/fimmu.2021.771619"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Sun L, Liu W, Li C, Zhang Y, Shi Y. Construction and internal validation of a predictive model for risk of gastrointestinal bleeding in children with abdominal Henoch-Sch\u00f6nlein purpura: A single-center retrospective case-control study. Front Immunol. 2022;13:1025335. doi:10.3389\/fimmu.2022.1025335","DOI":"10.3389\/fimmu.2022.1025335"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Kaya Akca U, Atalay E, Cuceoglu MK, et al. Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases. Rheumatol Int. 2022;42(1):51-57. doi:10.1007\/s00296-021-05027-7","DOI":"10.1007\/s00296-021-05027-7"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Dyga K, Szczepa\u0144ska M. IgA vasculitis with nephritis in children. Adv Clin Exp Med. 2020;29(4):513-519. doi:10.17219\/acem\/112566","DOI":"10.17219\/acem\/112566"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Ambatipudi S, Sharp GC, Clarke SLN, et al. Assessing the Role of DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio in Rheumatoid Arthritis. J Immunol Res. 2018;2018:2624981. doi:10.1155\/2018\/2624981","DOI":"10.1155\/2018\/2624981"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Adiguzel Dundar H, Acari C, Turkucar S, Unsal E. Treatment of systemic JIA: When do we need a biologic? Real world data of a single center. Mod Rheumatol. 2021;31(3):684-690. doi:10.1080\/14397595.2020.1761079","DOI":"10.1080\/14397595.2020.1761079"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Haybar H, Pezeshki SMS, Saki N. Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis? Exp Mol Pathol. 2019;110:104267. doi:10.1016\/j.yexmp.2019.104267","DOI":"10.1016\/j.yexmp.2019.104267"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"de Jong MC, Mihai R, Khan S. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as possible prognostic mark\u00acers for patients undergoing resection of adrenocortical carcinoma. World J Surg. 2020;45(3):754-764. doi:10.1007\/s00268-020-05868-6","DOI":"10.1007\/s00268-020-05868-6"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Xu L, Li Y, Wu X. IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers. Front Immunol. 2022;13:921864. doi:10.3389\/fimmu.2022.921864","DOI":"10.3389\/fimmu.2022.921864"}],"container-title":["Acta medica Lituanica"],"original-title":[],"link":[{"URL":"https:\/\/www.journals.vu.lt\/AML\/article\/download\/33347\/36346","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journals.vu.lt\/AML\/article\/download\/33347\/37148","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journals.vu.lt\/AML\/article\/download\/33347\/37148","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journals.vu.lt\/AML\/article\/download\/33347\/36346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:41:45Z","timestamp":1753440105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journals.vu.lt\/AML\/article\/view\/33347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,12,4]]}},"URL":"https:\/\/doi.org\/10.15388\/amed.2024.31.2.4","relation":{},"ISSN":["2029-4174","1392-0138"],"issn-type":[{"type":"electronic","value":"2029-4174"},{"type":"print","value":"1392-0138"}],"subject":[],"published":{"date-parts":[[2024,12,26]]}}}